Comparison of human immunodeficiency virus type 1 (HIV-1) protease mutations in HIV-1 genomes detected in plasma and in peripheral blood mononuclear cells from patients receiving combination drug therapy

Journal of Clinical Microbiology

Volumn 37, Issue 5, 1999, Pages 1595-1597

  Koch, Nathalie ^a   Yahi, Nouara ^a   Ariasi, Franck ^b   Fantini, Jacques ^b   Tamalet, Catherine ^a  

^a TIMONE HOSPITAL   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; DIDANOSINE; INDINAVIR; LAMIVUDINE; NELFINAVIR; PROTEINASE; PROTEINASE INHIBITOR; RITONAVIR; SAQUINAVIR; STAVUDINE; VIRUS RNA; ZALCITABINE; ZIDOVUDINE;

ARTICLE; CLINICAL ARTICLE; CODON; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; GENETIC RESISTANCE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MONONUCLEAR CELL; NONHUMAN; PLASMA; PRIORITY JOURNAL; RNA ANALYSIS; TREATMENT OUTCOME; VIRUS GENOME; VIRUS MUTATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0032894290     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.37.5.1595-1597.1999     Document Type: Article

References (14)

1. Coffin, J. M. 1995. HIV population dynamics in vivo. Science 267:483-489.
2. Cornelissen, M., R. van der Burg, F. Zorgdrager, V. Lukashov, and J. Goudsmit. 1997. pol gene diversity of five human immunodeficiency virus type 1 subtypes: evidence for naturally occurring mutations that contribute to drug resistance, limited recombination patterns, and common ancestry for subtypes B and D. J. Virol. 71:6348-6358.
3. D'Aquila, R. T. 1996. Nucleoside and foscarnet - clinical aspects, p. 191-223. In D. D. Richman (ed.), Antiviral drug resistance. John Wiley & Sons, New York, N.Y.
4. Eberle, J., B. Bechowsky, D. Rose, U. Hauser, K. Von Der Helm, L. Gürtler, and H. Nitschko. 1995. Resistance of HIV type 1 proteinase inhibitor Ro 31-8959. AIDS Res. Hum. Retroviruses 11:671-676.
5. Hirsch, M. S., B. Conway, R. T. D'Aquila, V. A. Johnson, F. Brun-Vézinet, B. Clotet, L. M. Demeter, S. M. Hammer, D. M. Jacobsen, D. R. Kuritzkes, C. Loveday, J. W. Mellors, S. Vella, and D. D. Richman. 1998. Antiretroviral drug resistance testing in adults with HIV infection. Implications for clinical management. JAMA 279:1984-1991.
6. Kaye, S., E. Comber, M. Tenant-Flowers, and C. Loveday. 1995. The appearance of drug resistance-associated point mutations in HIV type 1 plasma RNA precedes their appearance in proviral DNA. AIDS Res. Hum. Retroviruses 11:1221-1225.
7. Kozal, M. J., R. W. Shafer, M. A. Winters, D. A. Katzenstein, and T. C. Merigan. 1993. A mutation in human immunodeficiency virus reverse transcriptase and decline in CD4 lymphocyte numbers in long-term zidovudine recipients. J. Infect. Dis. 167:526-532.
8. Leitner, T., E. Halapi, G. Scarlatti, P. Rossi, J. Albert, E. M. Fenyö, and M. Uhlen. 1993. Analysis of heterogeneous viral populations by direct DNA sequencing. BioTechniques 15:120-127.
9. Loveday, C., S. Kaye, M. Tenant-Flowers, M. Semple, U. Ayliffe, I. V. Weller, and R. S. Tedder. 1995. HIV-1 RNA serum-load and resistant viral genotypes during early zidovudine therapy. Lancet 345:820-824.
10. Pazzani, M. J., D. See, E. Schroeder, and J. Tilles. 1997. Application of an expert system in the management of HIV-infected patients. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 15:356-362.
11. Richman, D. D. 1995. Protease uninhibited. Nature 374:494.
12. Rosenblum, B. B., L. G. Lee, S. L. Spurgeon, S. H. Khan, S. M. Menchen, C. R. Heiner, and S. M. Chen. 1997. New dye-labeled terminators for improved DNA sequencing patterns. Nucleic Acids Res. 25:4500-4504.
13. Smith, M. S., K. L. Koerber, and J. S. Pagano. 1993. Zidovudine-resistant human immunodeficiency virus type 1 genomes detected in plasma distinct from viral genomes in peripheral blood mononuclear cells. J. Infect. Dis. 167: 445-448.
14. Zhang, Y. M., S. C. Dawson, D. Landsman, H. C. Lane, and N. P. Salzman. 1994. Persistence of four related human immunodeficiency virus subtypes during the course of zidovudine therapy: relationship between virion RNA and proviral DNA. J. Virol. 68:425-432.